Skip to main content

Table 1 Differences in baseline characteristics between responders and non-responders

From: MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis

Baseline characteristic

Responders

Non-responders

 

(n = 66)

(n = 22)

Female gender, n (%)

48 (73)

18 (82)

Age at onset of JIA in years, median (IQR)

10.0 (4.2–12.3)

9.4 (3.5–13.7)

Disease duration in years, median (IQR)

2.4 (1.1–4.9)

2.3 (0.8–7.7)

JADAS-10, median (IQR)

20 (14–21)

17 (11–22)

CHAQ score, median (IQR)

1.5 (0.7–2.2)

1.3 (0.6-2.0)

Number of active joints, median (IQR)

11 (5–18)

8 (2–16)

ESR in mm/h, median (IQR)

16 (9–28)

12 (7–18)

Number of previously used DMARDs, median (IQR)

1 (1–2)

1 (1–2)

  1. JIA juvenile idiopathic arthritis, JADAS juvenile arthritis disease activity score, IQR interquartile range, ESR erythrocyte sedimentation rate, CHAQ child health assessment questionnaire, DMARDs disease modifying anti-rheumatic drugs